Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 22: 3722-3726, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-27743513

RESUMO

BACKGROUND Prostatitis is a common and refractory urological disease with complicated etiology. Ureaplasma urealyticum (UU) has a close relationship with human urinary tract infection that can induce nonbacterial prostatitis. Tripterygium wilfordii polyglycoside (TWP) is a non-steroidal immune inhibitor that causes significant immune suppression and anti-inflammatory effects. Its role in prostatitis caused by UU has not yet been established. The aim of this study was to investigate the effect of TWP on UU-infected prostatitis in a rat model. MATERIAL AND METHODS UU-infected prostatitis SD model rats were randomly divided into 2 groups: the prostatitis group (model group) and the TWP treatment group (treatment group). At 7 days after treatment, prostate weight, leucocyte count, lecithin corpuscles, UU infection rate, and UU microbe count were compared between the 2 groups. Serum inflammatory cytokines TNF-α was determined by ELISA, and ICAM-1 and NF-κB expression were detected. RESULTS UU infection rate was 80% after modeling. The rat prostate weight and leucocyte count in the model group increased significantly, while lecithin corpuscles decreased. Compared with controls, inflammatory factor TNF-α, ICAM-1, and NF-κB expression were obviously higher (P<0.05). TWP markedly reduced prostate weight and leucocyte count, increased lecithin corpuscles, and decreased UU microbe count and TNF-α, ICAM-1, and NF-κB expression (P<0.05). CONCLUSIONS TWP can inhibit expression of inflammatory factors and may be useful in treating UU-infected prostatitis through reducing UU infection rate.


Assuntos
Glicosídeos/farmacologia , Prostatite/tratamento farmacológico , Tripterygium/química , Infecções por Ureaplasma/tratamento farmacológico , Ureaplasma urealyticum/efeitos dos fármacos , Animais , Citocinas/sangue , Modelos Animais de Doenças , Molécula 1 de Adesão Intercelular/sangue , Masculino , NF-kappa B/sangue , Prostatite/sangue , Prostatite/microbiologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/sangue , Infecções por Ureaplasma/sangue , Infecções por Ureaplasma/microbiologia
2.
Artigo em Russo | MEDLINE | ID: mdl-23805671

RESUMO

AIM: Study of possibility of generalization of mycoplasma infection in patients with urogenital pathology. MATERIALS AND METHODS: Among the examined patients 5 males characterized by risky sexual behavior with pronounced symptoms of infection or without those were selected. Patients were examined by a complex of methods for the presence of mycoplasma infection by culture, PCR, DFA, PHA, AHR and by detection of specific immune complexes in blood sera. Scrapes from urogenital tract, blood sera samples, urine, saliva, prostatic fluid were materials for the study. RESULTS: In blood of all patients in ELISA antibodies against Mycoplasma hominis were detected; in PHA they were detected only in 2 individuals. In all the patients in blood CIC were detected including antigens and DNA of one or several mycoplasma species. Sperm of 3 individuals was infected by Ureaplasma spp., 2--M. genitalium. In saliva of 2 individuals M. hominis was detected, 3--U. urealyticum. CONCLUSION: In all the examined patients the infection was shown to have generalized character. This phenomenon presents itself as quite significant because mycoplasma may cause anti-apoptotic and oncogenic effect.


Assuntos
Infecções por Mycoplasma/microbiologia , Mycoplasma genitalium/isolamento & purificação , Mycoplasma hominis/isolamento & purificação , Infecções por Ureaplasma/microbiologia , Ureaplasma urealyticum/isolamento & purificação , Adulto , Anticorpos Antibacterianos/sangue , Complexo Antígeno-Anticorpo/sangue , Ensaio de Imunoadsorção Enzimática , Humanos , Masculino , Infecções por Mycoplasma/sangue , Infecções por Mycoplasma/imunologia , Infecções por Mycoplasma/urina , Mycoplasma genitalium/crescimento & desenvolvimento , Mycoplasma hominis/crescimento & desenvolvimento , Reação em Cadeia da Polimerase , Próstata/metabolismo , Próstata/microbiologia , Assunção de Riscos , Saliva/microbiologia , Espermatozoides/microbiologia , Infecções por Ureaplasma/sangue , Infecções por Ureaplasma/imunologia , Infecções por Ureaplasma/urina , Ureaplasma urealyticum/crescimento & desenvolvimento
3.
Arch Dis Child Fetal Neonatal Ed ; 93(1): F51-4, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17405871

RESUMO

OBJECTIVE: To determine the fetal cortisol response to intrauterine infection. STUDY DESIGN: 16s ribosomal RNA genes or the urease genes of Ureaplasma spp were identified by the polymerase chain reaction in intrauterine samples. Cord blood cortisol, interleukin 6 (IL6) and IL8 were measured in samples from 31 infants born at <32 weeks gestation. RESULTS: 13 infants (median gestation 30 weeks, birth weight 1350 g) had at least one positive intrauterine sample for microbial genes and 18 infants (31 weeks, 1320 g) did not. The cord blood cortisol concentration was significantly higher in fetuses exposed to intrauterine infection and significantly increased in fetuses/mothers presenting in preterm labour with intact membranes compared with infants delivered by elective prelabour caesarean section (p<0.05). The cord blood cortisol concentration was increased in the mothers with prelabour premature rupture of membranes but this was not significant compared with the caesarean section group. The cord blood cortisol concentration was significantly increased in the presence of chorioamnionitis or funisitis and was moderately correlated with cord blood IL6 (r = 0.64, p<0.01) and IL8 (r = 0.52, p<0.01). CONCLUSIONS: In this study, cord blood cortisol was increased in the colonised group compared with non-colonised infants. It is unclear if infants born following prelabour premature rupture of the membranes mount an adequate anti-inflammatory response.


Assuntos
Sangue Fetal/química , Hidrocortisona/sangue , Interleucina-6/sangue , Interleucina-8/sangue , Complicações Infecciosas na Gravidez/sangue , Infecções por Ureaplasma/sangue , Biomarcadores , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Trabalho de Parto , Reação em Cadeia da Polimerase , Gravidez , RNA Ribossômico 16S/isolamento & purificação , Ureaplasma/genética , Ureaplasma/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA